These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33616182)

  • 1. SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis.
    Imperatore N; Bennato R; D'Avino A; Lombardi G; Manguso F
    Inflamm Bowel Dis; 2021 Jun; 27(7):e87-e88. PubMed ID: 33616182
    [No Abstract]   [Full Text] [Related]  

  • 2. Can COVID-19 Trigger De Novo Inflammatory Bowel Disease?
    Taxonera C; Fisac J; Alba C
    Gastroenterology; 2021 Mar; 160(4):1029-1030. PubMed ID: 33221408
    [No Abstract]   [Full Text] [Related]  

  • 3. Onset of ulcerative colitis during SARS-CoV-2 infection.
    Calabrese E; Zorzi F; Monteleone G; Del Vecchio Blanco G
    Dig Liver Dis; 2020 Nov; 52(11):1228-1229. PubMed ID: 32601030
    [No Abstract]   [Full Text] [Related]  

  • 4. Case report: Immunological characteristics of
    Morita A; Imagawa K; Tagawa M; Sakamoto N; Takada H
    Front Immunol; 2023; 14():1107808. PubMed ID: 36875135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study.
    Lee JW; Song EM; Jung SA; Jung SH; Kim KW; Koh SJ; Lee HJ; Hong SW; Park JH; Hwang SW; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK; Park SH;
    J Korean Med Sci; 2021 Dec; 36(48):e336. PubMed ID: 34904410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020.
    Xu F; Carlson SA; Wheaton AG; Greenlund KJ
    Inflamm Bowel Dis; 2021 Jun; 27(7):1166-1169. PubMed ID: 33904584
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune Thrombocytopenic Purpura in a Child Following a SARS-CoV-2 Infection.
    Sivasankaran M; Siva Balan S; Munirathnam D
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1268-e1269. PubMed ID: 34673716
    [No Abstract]   [Full Text] [Related]  

  • 8. De Novo Pediatric Ulcerative Colitis Triggered by SARS-CoV-2 Infection: a Tale of 2 Sisters.
    Preziosi NA; Rizvi AH; Feerick JD; Mandelia C
    Inflamm Bowel Dis; 2022 Oct; 28(10):1623-1625. PubMed ID: 35762665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID19 induced acute pancreatitis and pancreatic necrosis in a patient with type 2 diabetes.
    Ghosh A; Gupta V; Misra A
    Diabetes Metab Syndr; 2020; 14(6):2097-2098. PubMed ID: 33152555
    [No Abstract]   [Full Text] [Related]  

  • 10. Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds.
    Bezzio C; Manes G; Bini F; Pellegrini L; Saibeni S
    Gut; 2021 Mar; 70(3):623-624. PubMed ID: 32554621
    [No Abstract]   [Full Text] [Related]  

  • 11. Considerations for the treatment of esophageal cancer during the COVID-19 pandemic.
    Davakis S; Karamouzis M; Ziogas D; Charalabopoulos A
    J BUON; 2021; 26(3):1171. PubMed ID: 34268989
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 infection in breast carcinoma patients.
    Adamopoulou M; Manaios L; Papouliakos S; Tsiambas E
    J BUON; 2021; 26(5):2207-2208. PubMed ID: 34761644
    [No Abstract]   [Full Text] [Related]  

  • 13. Valuing all lives equally: cancer surgery, COVID-19, and the NHS in crisis.
    The Lancet Oncology
    Lancet Oncol; 2021 Feb; 22(2):155. PubMed ID: 33539736
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?
    Attauabi M; Seidelin J; Burisch J;
    Gut; 2021 Oct; 70(10):2020-2022. PubMed ID: 33658323
    [No Abstract]   [Full Text] [Related]  

  • 15. A pandemic will not stop metabolic innovation.
    MacLeod E; Starin D; Ah Mew N; Regier DS
    Mol Genet Metab; 2020 Aug; 130(4):225-226. PubMed ID: 32461011
    [No Abstract]   [Full Text] [Related]  

  • 16. Ulcerative Colitis in a COVID-19 Patient: A Case Report.
    Aydın MF; Taşdemir H
    Turk J Gastroenterol; 2021 Jun; 32(6):543-547. PubMed ID: 34405821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
    Scucchi L; Neri B; Sarmati L; Mossa M; Sena G; Massoud R; Petruzziello C; Musumeci M; Marafini I; Calabrese E; Lolli E; Bernardini S; Andreoni M; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2418-2424. PubMed ID: 33755981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 on cancer patients: A review.
    Cavalcanti IDL; Soares JCS
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):186-192. PubMed ID: 32970923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care Coordination in a SARS-CoV-2-infected Child With Newly Diagnosed Medulloblastoma and Fanconi Anemia.
    Field MT; Chapple A; Hoeppner C; Boiko JR; Tellinghuisen A; Joshi S; Vitanza NA
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e972-e974. PubMed ID: 33235157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.
    Garnett C; Foldes D; Bailey C; Nesr G; Hui T; Hinton R; Gurung K; Phillips J; Saleem Z; Koshy R; Aduwa E; Colis M; Bimolah R; Katsomitrou V; Arami S; Kagdi H
    Leuk Lymphoma; 2021 Feb; 62(2):469-472. PubMed ID: 33167718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.